Researchers have already tackled complex problems regarding meizitang products

Researchers have already tackled complex problems regarding meizitang products.Agent can block the binding between the endogenous cannabinoid CBI receptor, leading to weight loss series with obesity. Related to body function improvement; Animal experiments have shown that, after fasting 18 h, knock addition to CBl receptor gene after small. Mice compared with wild-type eating less, even with high-fat diet, body weight and food intake is still reduced in pancreatic blood. Insulin and leptin levels also decreased, suggesting that CBl receptor of excitement in the diet-induced obesity in the development of. Play an important role [51. . 1.3.1 cannabinoid receptor type. . Cannabinoid receptors cannabinoid substances such as A9-of THC receptor response is clear cloning was.

meizitang has endured the inspection of market for more than a century.With drugs; mechanism can be divided into three categories [55 study: (1) appetite suppressant drug, usually on the central nervous. Or peripheral nerve, by affecting the appetite to reduce food intake. As well go to norepinephrine (NE) and 5. Serotonin (5.HT). Reuptake inhibitor, sibutramine, and norepinephrine. Adrenaline and dopamine (DA) reuptake inhibitor bupropion,. Cannabinoid Type 1 receptor antagonist rimonabant, pancreatic glucagon-like peptide-l (GLP.1). (2) inhibition of intestinal digestion.  Absorption of drugs, a major role in the gastrointestinal tract to reduce the energy absorption.

It I exciting to know and to experience the magic effect of losing weight by meizitang. Such as gastrointestinal lipase inhibitor orlistat. Him. (3) increasing the energy consumption of drugs, the role of metabolic processes to speed up energy consumption. Such as human growth hormone (HGH). The leptin (1eptin) and other. At present, for long-term treatment of obesity drugs by the U.S. Food and Drug Administration (FDA. Food and Drug Administration) approved the role of the central nervous system, sibutramine and role in peripheral. Organization of orlistat, as well as by the EU Quality of Medicines (EDQM, European Directorate for the. Quality of The Medicines) approved by the CB 1 receptor antagonist rimonabant.